CAS: 117928-94-6 - Rapastinel
- Synonyms:
- Glyx-13
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | GLYX 13 REF: IN-DA008TPGCAS: 117928-94-6 | 98% | 175.00 € | Wed 15 Jan 25 |
 | GLYX-13 trifluoroacetate REF: 7W-GK9893CAS: 117928-94-6 | ≥ 98.0% | To inquire | Thu 16 Jan 25 |
 | Rapastinel REF: TM-T3407CAS: 117928-94-6 | 98% | 47.00 €~336.00 € | Tue 21 Jan 25 |
 | GLYX 13 REF: 3D-FG170118CAS: 117928-94-6 | Min. 95% | - - - | Discontinued product |
Ref: IN-DA008TPG
| 5mg | 175.00 € |
Estimated delivery in United States, on Wednesday 15 Jan 2025
GLYX-13 trifluoroacetate
CAS:117928-94-6
Formula:
C18H31N5O6·xC2HF3O2
Purity:
≥ 98.0%
Color and Shape:
White to tan powder
Molecular weight:
413.47 (free base)
Ref: 7W-GK9893
| Undefined size | To inquire |
Estimated delivery in United States, on Thursday 16 Jan 2025
Rapastinel
CAS:117928-94-6
Rapastinel (TPPT-amide) (GLYX-13) is an N-methyl-D-aspartate receptor (NMDAR) modulator.
Formula:
C18H31N5O6
Purity:
98%
Color and Shape:
Solid
Molecular weight:
413.47
Ref: TM-T3407
| 1mg | 47.00 € | ||
| 5mg | 87.00 € | ||
| 10mg | 114.00 € | ||
| 25mg | 226.00 € | ||
| 50mg | 336.00 € | ||
| 1mL*10mM (DMSO) | 90.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
GLYX 13
CAS:117928-94-6
GLYX-13 is a novel, orally bioavailable, small-molecule drug that has been shown to have anti-cancer …
Formula:
C18H31N5O6
Purity:
Min. 95%
Molecular weight:
413.47 g/mol
Ref: 3D-FG170118
| 1mg | Discontinued | Request information | |
| 2mg | Discontinued | Request information | |
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information |
